TFAM公司
纤维化
炎症
肾
生物
MFN2型
癌症研究
线粒体生物发生
肾脏疾病
线粒体
细胞生物学
免疫学
线粒体DNA
医学
病理
内分泌学
线粒体融合
基因
生物化学
作者
Ki Wung Chung,Poonam Dhillon,Shizheng Huang,Xin Sheng,Rojesh Shrestha,Chengxiang Qiu,Brett A. Kaufman,Jihwan Park,Liming Pei,Joseph A. Baur,Matthew Palmer,Katalin Suszták
出处
期刊:Cell Metabolism
[Elsevier]
日期:2019-08-29
卷期号:30 (4): 784-799.e5
被引量:397
标识
DOI:10.1016/j.cmet.2019.08.003
摘要
Fibrosis is the final common pathway leading to end-stage renal failure. By analyzing the kidneys of patients and animal models with fibrosis, we observed a significant mitochondrial defect, including the loss of the mitochondrial transcription factor A (TFAM) in kidney tubule cells. Here, we generated mice with tubule-specific deletion of TFAM (Ksp-Cre/Tfamflox/flox). While these mice developed severe mitochondrial loss and energetic deficit by 6 weeks of age, kidney fibrosis, immune cell infiltration, and progressive azotemia causing death were only observed around 12 weeks of age. In renal cells of TFAM KO (knockout) mice, aberrant packaging of the mitochondrial DNA (mtDNA) resulted in its cytosolic translocation, activation of the cytosolic cGAS-stimulator of interferon genes (STING) DNA sensing pathway, and thus cytokine expression and immune cell recruitment. Ablation of STING ameliorated kidney fibrosis in mouse models of chronic kidney disease, demonstrating how TFAM sequesters mtDNA to limit the inflammation leading to fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI